Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study

Figures & data

Table 1. Demographics and clinical characteristics of patients.

Category	Subgroup	Number (%)
Age	Under 30 years	3(4.21%)
	31–50 years	23(32.39%)
	51–60 years	12(16.91%)
	61–80 years	24(33.76%)
Gender	Male	31(43.66%)
	Female	34(47.88%)
Working status	Working	46(65%)
	Retired	21(29.58%)
	No data	4(5.63%)
Smoking status	No smokers	58(81.69%)
	Ex-smokers	1(1.41%)
	Smokers	12(16.9%)
Occupational risk factor	Yes	3(4.22%)
	No	68(95.78%)
Category	Subgroup	Number (%)
Clinical data
Duration of asthma	<1 year	3(4.22%)
	1–5 years	18(25.35%)
	>5yearrs	48(67.71%)
Mean durability		14.95 ± 10.69 years
FEV1 ^a	<60%	27(38.02%)
	60–80%	18(25.35%)
	>80%	22(30.98%)
Mean FEV1		71.95 ± 22.15%
FVC ^b
	<60%	11(15.49%)
	60–80%	24(33.8%)
	>80%	30(42.25%)
Mean value		80.54 ± 20.72%
Tiffeneau–Pinelli index FEV1/FVC (%)
	>75%	40(56.34%)
	<75%	25(35.21%)
Mean value		79.69 ± 17.37%
Patient reported outcomes
EQ5D	1	28(39%)
Mean value	0.814 ± 0.22
ACTQ	<1	27(38%)
	1–2	28(39%)
	> =3	15(21%)
Mean value		1.29 ± 1.21
ACT	<20 p.	42(59%)
	>20 p.	29(41%)
Mean value		16.92 ± 5.68

a FEV1: forced expiratory volume.

b FVC: forced vital capacity.

Figure 1. The values of EQ5D results.

Figure 2. Mean score of ACTQ results according to severity of asthma.

Figure 3. Mean score of ACT results according to burden of asthma.

Table 2. Concomitant diseases in patients with asthma (no data for seven patients).

Concomitant diseases	Total (%)	Mild asthma N = 8(11.2%)	Moderate asthma N = 20(28%)	Severe asthma N = 27(38%)	Allergic rhinitis N = 9
Yes	57(80.29%)	6(75%) of 8	17(85%) of 20	22(81%) of 27	6(67%) of 9
No	14(19.71%)	2(25%)	3(15%)	5(19%)	3(33%)
> =2 diseases	31(54%)	0	11(55%)	15(55%)	4(67%)
1 diseases	17(26%)	6(75%)	6(30%)	7(26%)	2(33%)

Figure 4. Satisfaction of the patients from treatment.

Data availability statement

The data that support the findings of this study are available on request from the corresponding author, [PM]. The data are not publicly available due to [restrictions, e.g. their containing information that could compromise the privacy of research participants].